Bristol-Myers Squibb Company (BMY): A Bull Case Theory

We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY. BMY Technologies, Inc. share was trading at $53.96 as of Oct 4th. BMY’s trailing and forward P/E were 22.79 and 7.70 respectively according to Yahoo Finance.

A supportive smile shared between a care facility staff member and a resident with Alzheimer’s or Dementia.

Bristol-Myers Squibb (BMY) a drug...